Amneal And mAbxience Ally On Denosumab In US

Deal Agreed Between Partners On Biosimilar Candidates Referencing Prolia And Xgeva

 
• By David Wallace
Amneal HQ building sign
Amneal has added two denosumab biosimilars to its pipeline • Source: Shutterstock

More from Deals

More from Business